Drug Shortage Report for VINORELBINE INJECTION, USP

Last updated on 2019-03-15
Report ID 73634
Drug Identification Number 02431130
Brand name VINORELBINE INJECTION, USP
Common or Proper name 10 mg/ml Vinorelbine (as vinorelbine tartrate)
Company Name GENERIC MEDICAL PARTNERS INC
Active Ingredient(s) VINORELBINE
Strength(s) 10MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 5 ML IN CLEAR GLASS VIAL
ATC code L01CA
ATC description PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2019-02-25
Actual start date
Estimated end date 2019-03-14
Actual end date 2019-03-14
Shortage status Resolved
Updated date 2019-03-14
Company comments The latest batch of Vinorelbine 10mg/ml 5 ml vials has cleared QA and have been released. Regular supply of both Vinorelbine 10mg/ml 5 ml and 1 ml vials has now been re-established. The allocation process set in place for 5 ml vials with contracted accounts has been removed. GMP did not have a complete shortage during the allocation process. There is already an existing supply of Vinorelbine 10mg/ml 1 ml vials to meet usual national requirements.
Health Canada comments
Contact Address 251 CONSUMERS ROAD
TORONTO, ONTARIO
CANADA M2J 4R3
Company contact information